What Disqualifies You From Being an Organ Donor?

Almost nothing permanently disqualifies you from being an organ donor. The list of absolute medical contraindications is far shorter than most people assume, and it has been shrinking for decades as transplant medicine advances. Conditions like HIV, hepatitis C, cancer history, and even active bacterial infections that once ruled someone out are now, under the right circumstances, compatible with successful donation. The real question is rarely “can this person donate?” but rather “which organs are safe to use, and for which recipients?”

The True Absolute Disqualifications

If you are looking for a clean list of conditions that definitively rule out organ donation in every case, it is remarkably short. Active prion diseases, such as Creutzfeldt-Jakob disease (CJD), are among the very few remaining hard stops. Prions are misfolded proteins that cause fatal brain degeneration, cannot be destroyed by standard sterilization, and are transmissible through transplanted tissue. Some countries have implemented mandatory prion protein testing specifically to keep affected individuals out of the donor pool.¹

Beyond prion diseases, certain active disseminated cancers with no feasible treatment path and a handful of untreatable systemic infections round out the very short list of blanket exclusions. But even these categories have softened in recent years. The transplant community increasingly evaluates donors on a case-by-case basis rather than applying blanket rules, because the alternative for a dying patient on a waitlist is often no organ at all.

Cancer History Does Not Automatically Rule You Out

One of the most persistent myths is that anyone who has ever had cancer cannot donate organs. In reality, many people with a cancer history are eligible, and some can donate even with an active tumor under specific conditions. The key factor is the type, stage, and grade of the cancer, along with how long ago it was treated.

Small kidney cancers are a useful example. Renal cell carcinomas under four centimeters with low-grade pathology can be resected from the donor kidney, and the remaining kidney can still be transplanted as long as clean surgical margins are achieved.² That same review makes the broader point clearly: a history of malignancy, or even an active malignant disease in a potential donor, should not automatically veto organ donation.²

The cancers that remain true dealbreakers tend to be aggressive metastatic diseases with a high risk of transmission to the recipient, such as advanced melanoma, certain sarcomas, or active leukemia. Low-grade skin cancers, some brain tumors that rarely spread outside the skull, and cancers that were treated and cured years ago are often compatible with donation. Transplant teams weigh the risk of cancer transmission against the risk of the recipient dying without an organ, and that calculation increasingly favors using the organ.

Infections That Used to Disqualify Donors

HIV was once an absolute contraindication to organ donation. If a potential donor tested positive, every organ was discarded. That changed in the United States with the HIV Organ Policy Equity (HOPE) Act, which now allows organs from HIV-positive donors to be transplanted into HIV-positive recipients with end-stage organ disease.³ The Department of Health and Human Services revised federal regulations accordingly, permitting these transplants under research protocols that meet criteria published by the National Institutes of Health.⁴

Hepatitis C followed a similar trajectory. Donors who test positive for hepatitis C antibodies or active virus were historically excluded, but the arrival of direct-acting antiviral medications changed the equation. Research on kidney transplants from hepatitis C-positive donors found no meaningful difference in graft survival at three years compared to organs from uninfected donors.⁵ Recipients can now be treated and cured of hepatitis C after transplant, making what was once a disqualifier into a manageable condition.

Even acute bacterial infections do not necessarily rule out donation. Donors who died from bacterial meningitis, for instance, have successfully provided organs for transplantation. One study documented successful outcomes from liver, kidney, heart-lung, and pancreas transplants using organs from donors whose cause of death was bacterial meningitis or acute bacterial epiglottitis.⁶ The donor receives antibiotics before organ recovery, and the recipient is treated prophylactically. The infection itself, provided it has not destroyed the organs, is not the barrier people assume.

Drug Overdose and Substance Use

A common misconception is that people who die from drug overdoses cannot be organ donors. The opposite trend has been playing out in the United States. Overdose-death donors grew from about one percent of all deceased donors in 2000 to over thirteen percent by 2017.⁷ These donors tend to be younger adults, and their organs often function well despite the circumstances of death.

That said, donors who died from overdose are more likely to carry hepatitis C and to be classified as increased-infectious-risk donors, which means recipients are informed of the elevated risk and monitored closely.⁷ But as the hepatitis C treatment revolution has shown, that label is increasingly a manageable footnote rather than a barrier. The opioid crisis, as devastating as it has been, has become one of the largest new sources of transplantable organs in the country.

Certain poisoning scenarios do create real problems, though. Cyanide poisoning, for example, damages tissues that depend heavily on oxygen-based metabolism, particularly the brain and heart, which can make those organs unsuitable for transplant even when the donor is otherwise healthy.⁸ Carbon monoxide poisoning raises similar concerns. In these cases, individual organs are assessed for viability rather than the donor being ruled out entirely.

What Disqualifies Living Donors

The rules for living donors are stricter than for deceased donors, and for good reason: the surgery has to be safe for someone who is healthy and plans to stay that way. Living donor evaluation serves two goals simultaneously. The first is protecting the recipient by ensuring the donated organ is in good shape. The second, and arguably more important, is protecting the donor from unnecessary harm.

The medical conditions that lead to living donor denial vary by transplant center, but common absolute contraindications include diabetes or pre-diabetes, uncontrolled hypertension, obesity with a body mass index of thirty or above, fatty liver disease, and blood in the urine. At one major center, about a third of denied living donors had at least one of these absolute contraindications.⁹

For living liver donation specifically, anatomical factors play a large role. Variations in bile duct anatomy, unusual blood vessel arrangements, or insufficient liver volume remaining after the donor portion is removed can all rule someone out. One study found that about eight percent of potential living liver donors were excluded due to fatty liver, another eight percent for bile duct anatomy, two percent for vascular anatomy, and about ten percent because the remaining liver volume after donation would be too small for the donor’s safety.¹⁰

Mental health and decision-making capacity matter too. Potential living donors with significant psychiatric conditions are routinely evaluated and may be rejected, not because of any stigma, but because the transplant team needs to confirm the decision to donate is made voluntarily, without coercion, and by someone who fully understands the risks.¹¹ If that assurance cannot be established, the donation does not proceed. Centers that reject donors on psychiatric grounds typically provide referrals for care.¹¹

Organ-Specific Criteria and the Timing Factor

Even when a deceased donor is medically eligible, not every organ from that donor will necessarily be transplantable. Each organ has its own set of quality criteria, and an organ that fails one set of standards may still be perfectly fine for a different recipient or different organ system.

Lungs are among the most sensitive. Donor smoking history, for instance, can reduce recipient survival after lung transplantation, but transplant teams often proceed anyway because the alternative for the recipient is remaining on the waitlist indefinitely. Initial measures of lung oxygen exchange that fall below ideal thresholds should not automatically lead to rejection either. Recruitment techniques, essentially reinflating collapsed areas of the lung, can bring function up to transplantable levels.¹²

Timing is another critical variable. For organs recovered after circulatory death (as opposed to brain death), the period of reduced oxygen before the organ is preserved directly affects viability. Research on liver transplants from these donors found that the crucial factor is how long the liver goes without adequate oxygen, not just how long blood pressure is low. When the period of inadequate oxygen lasted longer than about thirteen minutes before asystole and organ recovery, recipients had more complications and higher rates of graft loss in the first ninety days.¹³ That research suggested that transplant teams should set a total warm ischemia cutoff of about thirty minutes. Beyond that, the liver may be too damaged to use, even if the donor is otherwise ideal.

Neonates and Pediatric Donors

Very young donors present their own challenges. Newborns who die in neonatal intensive care units are rarely evaluated as potential organ donors, partly because so many neonatal deaths involve conditions that make donation impossible. A study spanning eleven years at two neonatal units found that of 259 term neonates who died, roughly half were excluded immediately due to congenital disorders like chromosomal anomalies, metabolic conditions, or congenital heart disease. An additional group was excluded for active infections or tumors.¹⁴

Of the neonates who made it past the initial screen, another wave was excluded upon closer review for multi-organ failure, additional metabolic conditions, or incomplete medical records.¹⁴ The result is that very few neonatal deaths currently translate into organ donation, though researchers have argued that more could be identified if screening were routine. The barrier is not a blanket age disqualification but rather the high prevalence of conditions incompatible with donation in this population.

Incarceration and Organ Donation Policies

A less discussed but significant barrier to donation is incarceration. In the United States, organ donation policies for incarcerated individuals vary widely across prison systems. A review of policies from fifty-three carceral systems found that only twenty-one had written policies addressing donation at all. Of those, fifteen permitted living donation and thirteen allowed individuals to register for posthumous donation. Twelve systems limited living donation to family members only, including the Federal Bureau of Prisons, which specified living donation to immediate family.¹⁵

This means that in many jurisdictions, incarcerated people face practical disqualification from organ donation not because of any medical reason, but because of institutional policy gaps or restrictions. Since the United States has one of the largest incarcerated populations in the world, these policies affect a meaningful number of potential donors. The ethical questions here are thorny: concerns about informed consent and coercion in a prison setting are legitimate, but so is the argument that blanket restrictions deny people a basic act of autonomy.

How Technology Is Shrinking the Disqualification List

Machine perfusion is one of the most significant developments in transplant medicine over the past two decades, and it is directly responsible for making previously unusable organs viable. Instead of storing a donated organ on ice (the traditional method), machine perfusion continuously pumps oxygenated fluid through the organ, keeping its cells alive and allowing transplant teams to assess function before committing to the transplant.¹⁶

This technology is especially valuable for organs from older donors, donors with pre-existing conditions, or organs that sustained more ischemic injury than usual during recovery. Research has shown that machine perfusion reduces inflammation in the organ, flushes out donor immune cells that could trigger rejection, and can reverse some of the damage caused by oxygen deprivation.¹⁷ Experimental work has demonstrated that organs previously considered too damaged to transplant could be recovered to a usable state through continuous perfusion.¹⁸

The practical implication is that conditions and circumstances that would have disqualified a donor organ ten or fifteen years ago are increasingly being overcome by technology. An older donor with some fatty liver, a donor whose organs spent slightly too long in warm ischemia, a donor with a treatable infection: these scenarios that once meant discarded organs now often result in successful transplants. The gap between “disqualified” and “eligible” continues to narrow.

Age, Weight, and Common Misconceptions

There is no upper age limit for deceased organ donation. People in their seventies, eighties, and occasionally even nineties have donated organs successfully. The transplant team evaluates organ function, not the donor’s birth certificate. A healthy seventy-five-year-old’s kidneys may work better than those of a fifty-year-old with poorly controlled diabetes.

Weight and body size are more nuanced. For deceased donation, obesity alone does not disqualify you, though it can make certain organs less usable. Fatty infiltration in the liver, for instance, is common in people with higher body weight and can affect liver graft function. For living donation, as noted earlier, a BMI of thirty or above is considered an absolute contraindication at many centers, partly because of the increased surgical risk to the donor and partly because fatty liver is more prevalent in that population.

Another persistent myth is that registering as an organ donor means doctors will not try as hard to save your life. This has no basis in reality. The medical team treating you in an emergency has no knowledge of or involvement in organ donation decisions, which are handled by entirely separate organizations and personnel. Donation is not even considered until all life-saving measures have been exhausted and death has been declared.

People with chronic conditions like well-managed diabetes, high blood pressure, or autoimmune diseases often assume they cannot be deceased donors. In many cases, they can. The transplant team assesses whether specific organs have been damaged by the condition. You might not be able to donate kidneys if yours show signs of diabetic damage, but your corneas, skin, or even your heart might be perfectly usable. Donation is evaluated organ by organ and tissue by tissue, not as a yes-or-no question about the whole person.

Genetic Conditions and Transplant Decisions

Genetic disorders introduce a layer of complexity that transplant medicine is still working through. On the donor side, certain inherited metabolic conditions can make organs unsafe, particularly in neonatal donors where chromosomal and metabolic disorders are a leading reason for exclusion. On the recipient side, genetic risk factors increasingly figure into listing decisions.

A national survey of pediatric transplant programs found that many programs treat genetic cancer predispositions and adult-onset neurological conditions as relative contraindications when deciding whether to list a child for transplant. A smaller number of programs treat such findings as absolute contraindications. About two-thirds of programs have required genetic testing for specific indications before making listing decisions.¹⁹ This is a rapidly evolving area where the science of genetic risk assessment is outpacing the ethical frameworks for how to use it. Whether a genetic finding should affect a donor’s or recipient’s eligibility remains a subject of active debate, and there is no universal standard.

For potential donors worried about whether a family history of genetic conditions disqualifies them: it almost certainly does not for deceased donation. The transplant team evaluates the organs themselves. A donor carrying a gene for a condition that has not affected their organ function is still a viable donor. Living donation is more cautious, because the screening process is also protecting the donor from the consequences of surgery with one fewer organ, and certain genetic risks to the donor’s future health could tip the balance toward declining.